Potentially a very valuable one.
I like that, at the end of the article, they remind us that even if this turns out to be clinically useful, in the long run bacteria will evolve that are resistant to this one too.The Merck researchers addressed both problems with a clever genetic trick that made an existing drug-hunting process more effective and also targeted novel types of antibiotics.
Their innovation was to test extracts of fungi, plants and other natural substances against bacteria with a genetically engineered Achilles’ heel. Because the bacteria were weakened, any compound that harmed them would have a more dramatic effect and thus be easier to identify.
The Merck scientists also chose the genetic handicap carefully, placing it in a metabolic pathway that is not attacked by any major existing antibiotics. That increased the likelihood that any promising compound they discovered would be something for which the bacteria had not yet developed a resistance.